Request Free Sample
×
India Calciphylaxis Market
ID: MRFR/HC/56499-HCR
200 Pages
June 2025
India Calciphylaxis Market Research Report: By Diagnosis (Deep Skin Biopsies, Blood Tests, Imaging), By Treatment (Intensive Wound Care, Medication, Therapy, Clot-Dissolving)and By End User (Hospitals, Clinics, Medical Research Centers) - Forecast to 2035
Industry Developments
In recent months, the India Calciphylaxis Market has seen heightened attention due to a growing acknowledgment of the condition linked to chronic kidney disease and its severe implications. Companies like Sun Pharmaceutical Industries and Torrent Pharmaceuticals are ramping up their research to develop treatment options tailored for Indian patients. Abbott India and Merck Limited have also intensified their focus on innovative therapies that target the mechanisms of Calciphylaxis. In terms of mergers and acquisitions, while there have been discussions within the sector, no major publicly known mergers have been reported in the recent time frame involving the highlighted companies from January to October 2023. The market valuation of firms such as Zydus Cadila and Cipla has steadily increased as a result of heightened investment in Research and Development aimed at improving patient outcomes. Over the last two to three years, initiatives to educate healthcare providers about Calciphylaxis have gained traction, significantly influencing diagnosis and treatment approaches across India. The coordination among pharmaceutical companies and renal health associations has played a vital role in increasing awareness and fostering collaboration in the Calciphylaxis therapeutic landscape.
Report Scope
Report Scope:
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 35.2(USD Million) |
| MARKET SIZE 2024 | 39.18(USD Million) |
| MARKET SIZE 2035 | 157.13(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 13.458% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | Sun Pharmaceutical Industries, Torrent Pharmaceuticals, Merck Limited, Abbott India, Pfizer India, Zydus Cadila, Intas Pharmaceuticals, Wockhardt, Aurobindo Pharma, Novartis India, Alkem Laboratories, Lupin Pharmaceuticals, Mylan, Cipla, Dr. Reddy's Laboratories |
| SEGMENTS COVERED | Diagnosis, Treatment, End User |
| KEY MARKET OPPORTUNITIES | Increasing prevalence of chronic kidney disease, Rising awareness and education initiatives, Development of innovative therapies, Expanding diagnostic and treatment facilities, Growing demand for specialized healthcare services |
| KEY MARKET DYNAMICS | Rising chronic kidney disease prevalence, Limited treatment options availability, Growing awareness among healthcare professionals, Increasing research funding, High healthcare costs in management |
| COUNTRIES COVERED | India |
FAQs
What is the expected market size of the India Calciphylaxis Market in 2024?
The India Calciphylaxis Market is expected to be valued at 39.18 million USD in 2024.
What will be the projected market size of the India Calciphylaxis Market by 2035?
By 2035, the India Calciphylaxis Market is projected to reach a value of 157.13 million USD.
What is the expected CAGR for the India Calciphylaxis Market from 2025 to 2035?
The expected CAGR for the India Calciphylaxis Market from 2025 to 2035 is 13.458 percent.
Which diagnosis segment will have the highest market value in 2035?
The Blood Tests segment is expected to have the highest market value at 64.3 million USD by 2035.
Which key players dominate the India Calciphylaxis Market?
Major players in this market include Sun Pharmaceutical Industries, Torrent Pharmaceuticals, Merck Limited, among others.
What is the expected market value for Deep Skin Biopsies in 2035?
The expected market value for Deep Skin Biopsies in 2035 is 51.2 million USD.
What is the market size of the Imaging diagnosis segment in 2024?
In 2024, the Imaging diagnosis segment is valued at 10.88 million USD.
How is the India Calciphylaxis Market expected to grow in the coming years?
The market is anticipated to experience significant growth, driven by increasing awareness and diagnosis practices.
What is the market value for Blood Tests in 2024?
The Blood Tests segment is valued at 15.8 million USD in the year 2024.
What are the key growth drivers for the India Calciphylaxis Market?
Key growth drivers include rising cases of chronic kidney diseases and improved diagnostic technologies.
Download Free Sample
Kindly complete the form below to receive a free sample of this Report
Customer Stories
“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”
Noah Malgeri
Co-Founder
“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”
Joseph Aguayo
Sales Operations & Pricing Manager
“Thanks for sending the report it gives us a good global view of the Betaïne market.”
Peter Groot koerkamp
Account and Business Manager
“Thank you, this will be very helpful for OQS.”
La Terria Dodd
Program Support Specialist
“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”
Younghwan Choi
Senior Retail Manager
“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”
Mark Irwin
Management Consultant
“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”
Rob Kooiker
Group Product Manager HVAC & Fire Protection GMA
“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”
Akif Moroglu
Strategy & Business Development Director
Case Study
Aerospace & Defense
Leave a Comment